Navigation Links
High and mighty: first common height gene identified by researchers behind 'obesity gene' finding
Date:9/2/2007

Whilst we all know that tall parents are more likely to have tall children, scientists have been unable to identify any common genes that make people taller than others. Now, however, scientists have identified the first gene, known as HMGA2, a common variant of which directly influences height.

The difference in height between a person carrying two copies of the variant and a person carrying no copies is just under 1cm in height, so does not on its own explain the range of heights across the population. However, the researchers believe the findings may prove important.

Previous studies have suggested that, unlike conditions such as obesity, which is caused by a mix of genetic and environmental factors so called "nature and nurture" 90% of normal variation in human height is due to genetic factors rather than, for example, diet. However, other than very rare gene variants that affect height in only a small number of people, no common gene variants have until now been identified.

The research was led by Dr Tim Frayling from the Peninsula Medical School, Exeter, Professor Mark McCarthy from the University of Oxford and Dr Joel Hirschhorn from the Broad Institute of Harvard and MIT in Cambridge, US. Dr Frayling and Professor McCarthy were also part of a Wellcome Trust-funded study team that discovered the first common gene linked to obesity in April this year.

Using data from the Wellcome Trust Case Control Consortium, the largest study ever undertaken into the genetics underlying common diseases, and the Diabetes Genetics Initiative, in the US, the researchers conducted a genome-wide study of DNA samples from 5,000 people. The findings that variations in the gene HMGA2 make some people taller than others are published online today in the journal Nature Genetics.

Each of us carries two copies of each gene, one from our mother and one from our father. However, each copy can be a variant, or "allele" in the case of the HMGA2 gene, a "tall" version and a "short" version. The researchers found that as many as 25% of white Europeans carried two "tall" versions of this particular gene, making them approximately 1cm taller than the 25% of people who carry two "short" versions.

"Height is a typical 'polygenic trait' in other words, many genes contribute towards making us taller or shorter," explains Dr Frayling. "Clearly, our results do not explain why one person will be 6'5" and another only 4'10". This is just the first of many that will be found possibly as many as several hundred."

The exact role that HMGA2 has in growth is unclear, but the researchers believe it is most likely in increased cell production. This may have implications for the development of cancer as tumours occur due to unregulated cell growth. Previous studies have shown an association between height and certain cancers: taller people are statistically more likely to be at risk from cancers, including those found in the prostate, bladder and lung.

"There appears to be a definite correlation between height and some diseases," explains Dr Mike Weedon, lead author on the study. "For example, there are associations between shortness and slightly increased risks of conditions such as heart disease. Similarly, tall people are more at risk from certain cancers and possibly osteoporosis."

Dr Frayling believes that the study has major implications for helping scientists understand how common variations in DNA in the human the genome actually affect us, especially in relation to growth and development.

"Even though improved nutrition means that each generation is getting successively taller, variation in height within a population is almost entirely influenced by our genes," says Dr Frayling. "This fact, coupled with the ease of measuring height, means that height can act as a model trait, allowing us to explore in detail the influence that the genome actually has on our general make-up, not just disease risk."

In addition to being a textbook example of a complex trait, height is a common reason children are referred to specialists. Although short stature by itself typically does not signify cause for concern, delayed growth can sometimes reflect a more serious underlying medical condition.

By defining the genes that normally affect stature, we might someday be able to better reassure parents that their childs height is within the range predicted by their genes, rather than a consequence of disease, said Dr Hirschhorn from the Broad Institute of Harvard and MIT.


'/>"/>
Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Infant receives first bloodless liver transplant
3. Oracle Corp. to help build worlds first "Digital Hospital"
4. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
5. First human clone is near
6. First Artificial Heart patient has Major setback
7. First global SARS meet opens
8. Launch Of India’s First Virology Course At Pun
9. FDA approves first pocket-sized EKG machine
10. First head-to-head trials of once weekly Fosamax and Actonel therapies
11. WHO Declares Vietnam First Country to Control SARS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers who were ... desire a more intimate review and analysis of its highlights, a novel half-day, complimentary ... offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... at the National Association of Music Merchants (NAMM) winter trade show, Booth #2876, ... , Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear earphones. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples ... the Peoples Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare ... Center is an exciting addition to our provider network, and the addition will ...
(Date:1/17/2017)... ... January 17, 2017 , ... Wettstein Agencies, a ... and business professionals throughout central Colorado, is joining local nonprofit Aurora Warms The ... Warms The Night organization is committed to breaking the cycle of homelessness and ...
(Date:1/17/2017)... ... 2017 , ... The Sharie Withers Agency, a full-service insurance ... beneficiary of their thriving community involvement program. The current campaign fundraises to support ... of terminally ill patients. Donations to this worthy cause may now be made ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)...  Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... a Phase 3 clinical trial comparing the efficacy and ... the prevention of hepatic veno-occlusive disease (VOD) in adult ... who are at high risk or at very high ... be conducted across approximately 100 medical centers in ...
(Date:1/17/2017)... 17, 2017  Edwards Lifesciences Corporation (NYSE: ... structural heart disease and critical care monitoring, plans to ... 31, 2016 after the market closes on Wednesday, February ... 5:00 p.m. ET that day to discuss those results. ... (877) 407-8037 or (201) 689-8037.  For 72 hours following ...
(Date:1/17/2017)... company that brought a full line of equine first aid kits ... of companion animal pet first aid kits.  EquiMedic USA ... developed two sizes of small pet first aid kits under the ... a small and a large companion pet first aid kit, this ... newcomer to working with small animals either. Corporate owners, mother and ...
Breaking Medicine Technology: